Yield10 Bioscience, Inc. (YTEN)
After hours: 04:16PM EDT
Chart Events
Performance Outlook
| Previous Close | 8.80 |
| Open | 8.14 |
| Bid | 8.82 x 1300 |
| Ask | 9.20 x 800 |
| Day's Range | 8.66 - 9.11 |
| 52 Week Range | 4.16 - 23.49 |
| Volume | 37,799 |
| Avg. Volume | 65,269 |
| Market Cap | 43.69M |
| Beta (5Y Monthly) | 1.22 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.30 |
| Earnings Date | Mar 16, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 25.33 |
- GlobeNewswire
Yield10 Bioscience Chief Science Officer Dr. Kristi Snell to Present on Advances Using Camelina Platform to Produce PHA Bioplastic at 2021 Synthetic Biology: Engineering, Evolution and Design Virtual Conference
WOBURN, Mass., June 16, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq:YTEN), an agricultural bioscience company, today announced that its Chief Science Officer Dr. Kristi Snell will present during the 2021 Synthetic Biology: Engineering, Evolution & Design (SEED) conference, taking place in a virtual format June 15 through June 18, 2021. Dr. Snell will present at the conference on Wednesday, June 16 at 10:55 am PDT (1:55 pm EDT) during Session 4: Synthetic Biology for Agriculture, Fo
- GlobeNewswire
Yield10 Bioscience to Present at the LD Virtual Invitational XI on June 9, 2021
WOBURN, Mass., May 27, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN), an agricultural bioscience company, today announced that Oliver Peoples, Ph.D., President and Chief Executive Officer of Yield10, will give a corporate presentation at the LD Micro Virtual Invitational XI investor conference on Wednesday, June 9, 2021 at 3:30 pm ET, Track Two. The virtual conference and presentation will be held via webcast from June 8 to 10, 2021. Register to watch the presentation here. Investors interested in scheduling a meeting with management should contact assistant@ldmicro.com. About Yield10 Bioscience Yield10 Bioscience, Inc. is an agricultural bioscience company that is using its differentiated trait gene discovery platform, the “Trait Factory”, to develop improved Camelina varieties for the production of proprietary seed products, and to discover high value genetic traits for the agriculture and food industries. Our goals are to efficiently establish a high value seed products business based on developing superior varieties of Camelina to produce feedstock oils, nutritional oils, and PHA bioplastics, and to license our yield traits to major seed companies for commercialization in major row crops, including corn, soybean and canola. Yield10 is headquartered in Woburn, MA and has an Oilseeds Center of Excellence in Saskatoon, Canada. For more information about the company, please visit www.yield10bio.com, or follow the Company on Twitter, Facebook and LinkedIn. (YTEN-G) Contacts: Yield10 Bioscience:Lynne H. Brum, (617) 682-4693, LBrum@yield10bio.com Investor Relations: Bret Shapiro, (561) 479-8566, brets@coreir.comManaging Director, CORE IR Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank PR
- CoinDesk
Is Yield10 Bioscience (NASDAQ:YTEN) In A Good Position To Deliver On Growth Plans?
Just because a business does not make any money, does not mean that the stock will go down. For example, although...
